Gladius Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-141
| Closed | -$36.5K | – | 265 |
|
|
2023
Q4 | $36.5K | Buy |
141
+32
| +29% | +$8.28K | 0.01% | 154 |
|
|
2023
Q3 | $28K | Buy |
+109
| New | +$28K | ﹤0.01% | 221 |
|
|
2022
Q4 | – | Sell |
-183
| Closed | -$49K | – | 310 |
|
|
2022
Q3 | $49K | Buy |
+183
| New | +$49K | ﹤0.01% | 149 |
|
|
2022
Q2 | – | Sell |
-773
| Closed | -$163K | – | 298 |
|
|
2022
Q1 | $163K | Buy |
+773
| New | +$163K | 0.01% | 121 |
|
|
2019
Q2 | – | Sell |
-4,200
| Closed | -$993K | – | 66 |
|
|
2019
Q1 | $993K | Buy |
4,200
+2,731
| +186% | +$646K | 0.05% | 48 |
|
|
2018
Q4 | $442K | Buy |
+1,469
| New | +$442K | 0.02% | 57 |
|